Iceland· IS-EU/1/19/1417/001
Beovu
A brolucizumab product containing brolucizumabum inn, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Brolucizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC S01LA06 (brolucizumab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Brolucizumab · ATC S01LA06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Brolucizumabum INN
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- S01LA06
- ATC class
- Brolucizumab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brolucizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeovu 120 mg/mlNovartis Europharm
- CzechiaBEOVUNovartis Europharm Limited, Dublin
- SwedenBeovu 120 mg/ml Injektionsvätska, lösningNovartis Europharm Limited
- SpainBEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
- FranceBEOVU 120 mg/ml, solution injectable en seringue préremplieNOVARTIS EUROPHARM (IRLANDE)
- IrelandBeovu 120 mg/ml solution for injection in pre-filled syringeNovartis Europharm Limited
- NetherlandsBeovu 120 mg/ml, oplossing voor injectieNovartis Europharm Limited
- SwitzerlandBeovu
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Beovu
- Norway · Beovu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4c088db-9c71-4d78-b4ba-d8bba68ba5ab GET /v1/drugs/d4c088db-9c71-4d78-b4ba-d8bba68ba5ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "S01LA06",
"marketed": false,
"strength": "120 mg/ml",
"ma_number": "EU/1/19/1417/001",
"substance": "Brolucizumabum INN",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43874"
}See everything about brolucizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.